Prognostic value of minimal residual disease measured by fusion‐gene transcript in infants with KMT2A‐rearranged acute lymphoblastic leukaemia treated according to the MLL‐Baby protocol
暂无分享,去创建一个
N. Ponomareva | N. Miakova | A. Kustanovich | O. Aleinikova | A. Popov | G. Tsaur | O. Streneva | E. Shorikov | A. Karachunskiy | L. Fechina | A. Solodovnikov | O. Makarova | T. Verzhbitskaya | K. Kondratchik | A. Demina | T. Riger | E. Boichenko | E. Lapotentova | A. Roumiantsev